Massmedica S.A. (WSE:MSM)

Market Cap	12.75M +53.9%
Revenue (ttm)	31.77M +8.7%
Net Income	618.27K +63.5%
EPS	0.26 +63.5%
Shares Out	2.41M
PE Ratio	20.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,032
Open	5.30
Previous Close	5.28
Day's Range	5.30 - 5.78
52-Week Range	3.26 - 7.50
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Massmedica

Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases, aesthetic and regenerative medicines in Poland. It provides products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include supplements, skin care, sun protection, creams, tools, serum, masks, carboxytheraphy, and intra-articular injections. It also offers reconstructive products, such as hip endoprostheses, 3D endoportesis, and synthetic tendon li...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 2011
• Employees: 14
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MSM

Financial Performance

In 2025, Massmedica's revenue was 32.22 million, a decrease of -1.20% compared to the previous year's 32.61 million. Earnings were 535,808, a decrease of -11.23%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 9, 2026

Data Sources Report a data error